Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis

@inproceedings{Hassan2017NoninvasiveBA,
  title={Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis},
  author={Elham Ahmed Hassan and Haidi K. Ramadan and Ali A. Ismael and Khaled F. Mohamed and Madiha M. El-Attar and Ihab Alhelali},
  booktitle={Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association},
  year={2017}
}
BACKGROUND/AIMS Treatment of refractory ulcerative colitis (UC) is a clinical challenge, and after biological therapy, monitoring clinical and endoscopic responses is fundamental. We aimed to investigate and compare the predictive power of different noninvasive parameters for clinical remission and mucosal healing after infliximab induction therapy in refractory UC patients. PATIENTS AND METHODS Serum and fecal biomarkers, including hemoglobin, white blood cells, erythrocyte sedimentation… CONTINUE READING